MEDTRONIC PLC. overview

Medtronic announces CMS national coverage analysis for Symplicity™ Spyral Renal Denervation System PR Newswire GALWAY, Ireland, Jan. 13, 2025 National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term data from the SPYRAL-HTN global clinical program GALWAY, Ireland , Jan. 13, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare...

Medtronic achieves CE Mark approval for BrainSense™ Adaptive deep brain stimulation and Electrode Identifier, a groundbreaking advance in personalized, sensing-enabled care for people with Parkinson's through innovative brain-computer interface technology PR Newswire GALWAY, Ireland, Jan. 13, 2025 European approval introduces the world's only closed-loop DBS system with real-time, self-adjusting brain stimulation for people with Parkinson's disease GALWAY, Ireland , Jan. 13, 2025 /PRNewswire/...

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference PR Newswire GALWAY, Ireland, Jan. 7, 2025 GALWAY , Ireland , Jan. 7, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025 . Geoff Martha , Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company...

Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference PR Newswire GALWAY, Ireland, Jan. 6, 2025 GALWAY , Ireland , Jan. 6, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced it will participate in the 43rd annual J.P. Morgan healthcare conference on Monday, January 13, 2025 . Geoff Martha , Medtronic chairman and chief executive officer, will make a formal presentation and answer questions on the company...

Medtronic announces cash dividend for third quarter of fiscal year 2025 PR Newswire GALWAY, Ireland, Dec. 5, 2024 GALWAY , Ireland , Dec. 5, 2024 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 5, 2024, approved the company's cash dividend for the third quarter of fiscal year 2025 of $0 .70 per ordinary share. This quarterly declaration is consistent with the dividend increase announcement made by the company in May 2024. Medtronic is a constituent of...

NORTHAMPTON, MA / ACCESSWIRE / November 21, 2024 / By Ken Washington, Chief Technology and Innovation Officer, and Raman Venkatesh, Chief Sustainability Officer, Medtronic When you think about healthcare technology, you may imagine the pacemaker assisting your dad's ailing heart, the sutures your child received after a bike accident, or the pulse oximeter placed on your finger during your annual physical exam. You probably don't think about the energy or resources required to manufacture those...

NORTHAMPTON, MA / ACCESSWIRE / November 20, 2024 / Medtronic: Medtronic releases 2024 Impact Report highlighting success in healthcare equity with new data from the Healthy Neighbor program, in addition to community engagement and environmental sustainability progress November 20, 2024 /3BL/ - Medtronic plc, a global leader in healthcare technology, has today released its fiscal year 2024 (FY24) Impact Report. The report highlights the company's continued commitment to advancing health equity,...